Literature DB >> 20552409

Long-term survival and recurrence outcomes following surgery for distal rectal cancer.

Eric J Silberfein1, Kiran M Kattepogu, Chung-Yuan Hu, John M Skibber, Miguel A Rodriguez-Bigas, Barry Feig, Prajnan Das, Sunil Krishnan, Christopher Crane, Scott Kopetz, Cathy Eng, George J Chang.   

Abstract

BACKGROUND: Treatment of distal rectal cancer remains clinically challenging and includes proctectomy and coloanal anastomosis (CAA) or abdominoperineal resection (APR). The purpose of this study is to evaluate operative and pathologic factors associated with long-term survival and local recurrence outcomes in patients treated for distal rectal cancer.
METHODS: A retrospective consecutive cohort study of 304 patients treated for distal rectal cancer with radical resection from 1993 to 2003 was performed. Patients were grouped by procedure (CAA or APR). Demographic, pathologic, recurrence, and survival data were analyzed utilizing chi-square analysis for comparison of proportions. Survival analysis was performed using Kaplan-Meier method and log-rank test for univariate and Cox regression for multivariate comparison.
RESULTS: The median tumor distance from the anal verge was 2 cm [interquartile range (IQR) 0.5-4 cm]. Margins were negative in all but four patients (one distal, 0.3%; three radial, 1%). The 5-year overall survival rate was 82% (88.6% stage pI, 80.5% stage pII, 67.9% stage pIII). Older age, advanced pathologic stage, presence of lymphovascular or perineural invasion, earlier treatment period, and APR surgery type were associated with worse survival on multivariate analysis. The 5-year local recurrence rate was 5.3% after CAA and 7.9% after APR (p = 0.33).
CONCLUSIONS: Low rates of local recurrence and good overall survival can be achieved after treatment of distal rectal cancer with stage-appropriate chemoradiation and proctectomy with CAA or APR. Sphincter preservation can be achieved even with distal margins less than 2 cm.

Entities:  

Mesh:

Year:  2010        PMID: 20552409      PMCID: PMC3071558          DOI: 10.1245/s10434-010-1119-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  40 in total

1.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

4.  Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival.

Authors:  N S Williams; M F Dixon; D Johnston
Journal:  Br J Surg       Date:  1983-03       Impact factor: 6.939

5.  Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient?

Authors:  B Kuvshinoff; I Maghfoor; B Miedema; M Bryer; S Westgate; J Wilkes; D Ota
Journal:  Ann Surg Oncol       Date:  2001-03       Impact factor: 5.344

6.  Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Authors:  Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

7.  Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.

Authors:  Harvey G Moore; Elyn Riedel; Bruce D Minsky; Leonard Saltz; Philip Paty; Douglas Wong; Alfred M Cohen; Jose G Guillem
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

8.  Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.

Authors:  Arne Wibe; Astri Syse; Elisabeth Andersen; Steinar Tretli; Helge E Myrvold; Odd Søreide
Journal:  Dis Colon Rectum       Date:  2004-01-14       Impact factor: 4.585

9.  Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.

Authors:  George J Chang; Miguel A Rodriguez-Bigas; Cathy Eng; John M Skibber
Journal:  Cancer       Date:  2009-12-01       Impact factor: 6.860

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  40 in total

1.  Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.

Authors:  Matthew H G Katz; Huamin Wang; Aparna Balachandran; Priya Bhosale; Christopher H Crane; Xuemei Wang; Peter W T Pisters; Jeffrey E Lee; Jean-Nicolas Vauthey; Eddie K Abdalla; Robert Wolff; James Abbruzzese; Gauri Varadhachary; Xavier Chopin-Laly; Chusilp Charnsangavej; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

2.  Factors influencing response to neoadjuvant chemoradiation and outcomes in rectal cancer patients: tertiary Indian cancer hospital experience.

Authors:  Reena Engineer; Trinanjan Basu; Supriya Chopra; Supreeta Arya; Prachi Patil; Shaesta Mehta; Mukta Ramadwar; Kedar Deodhar; Shyam Kishore Shrivastava
Journal:  J Gastrointest Oncol       Date:  2015-04

3.  Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.

Authors:  Ze-Yu Wu; Gang Zhao; Zhe Chen; Jia-Lin Du; Jin Wan; Feng Lin; Lin Peng
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

4.  Wound dehiscence after abdominoperineal resection for low rectal cancer is associated with decreased survival.

Authors:  Alexander T Hawkins; David L Berger; Paul C Shellito; Patrica Sylla; Liliana Bordeianou
Journal:  Dis Colon Rectum       Date:  2014-02       Impact factor: 4.585

Review 5.  Prognostic value of perineural invasion in colorectal cancer: a meta-analysis.

Authors:  Yuchong Yang; Xuanzhang Huang; Jingxu Sun; Peng Gao; Yongxi Song; Xiaowan Chen; Junhua Zhao; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2015-02-07       Impact factor: 3.452

6.  Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.

Authors:  George J Chang; Y Nancy You; In Ja Park; Harmeet Kaur; Chung-Yuan Hu; Miguel A Rodriguez-Bigas; John M Skibber; Randy D Ernst
Journal:  Dis Colon Rectum       Date:  2012-04       Impact factor: 4.585

7.  A novel risk-adjusted nomogram for rectal cancer surgery outcomes.

Authors:  Maria C Russell; Y Nancy You; Chung-Yuan Hu; Janice N Cormier; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Heidi Nelson; George J Chang
Journal:  JAMA Surg       Date:  2013-08       Impact factor: 14.766

8.  Laparoscopic salvage surgery for locally recurrent rectal cancer.

Authors:  Toshiya Nagasaki; Takashi Akiyoshi; Masashi Ueno; Yosuke Fukunaga; Satoshi Nagayama; Yoshiya Fujimoto; Tsuyoshi Konishi; Toshiharu Yamaguchi
Journal:  J Gastrointest Surg       Date:  2014-05-17       Impact factor: 3.452

Review 9.  Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.

Authors:  Valerie M Nelson; Al B Benson
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 10.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.